The Nephrologist's Role in the Collaborative Multi-Specialist Network Taking Care of Patients with Diabetes on Maintenance Hemodialysis: An Overview
- PMID: 35329847
- PMCID: PMC8949004
- DOI: 10.3390/jcm11061521
The Nephrologist's Role in the Collaborative Multi-Specialist Network Taking Care of Patients with Diabetes on Maintenance Hemodialysis: An Overview
Abstract
Diabetes mellitus is the leading cause of renal failure in incident dialysis patients in several countries around the world. The quality of life for patients with diabetes in maintenance hemodialysis (HD) treatment is in general poor due to disease complications. Nephrologists have to cope with all these problems because of the "total care model" and strive to improve their patients' outcome. In this review, an updated overview of the aspects the nephrologist must face in the management of these patients is reported. The conventional marker of glycemic control, hemoglobin A1c (HbA1c), is unreliable. HD itself may be responsible for dangerous hypoglycemic events. New methods of glucose control could be used even during dialysis, such as a continuous glucose monitoring (CGM) device. The pharmacological control of diabetes is another complex topic. Because of the risk of hypoglycemia, insulin and other medications used to treat diabetes may need dose adjustment. The new class of antidiabetic drugs dipeptidyl peptidase 4 (DPP-4) inhibitors can safely be used in non-insulin-dependent end-stage renal disease (ESRD) patients. Nephrologists should take care to improve the hemodynamic tolerance to HD treatment, frequently compromised by the high level of ultrafiltration needed to counter high interdialytic weight gain. Kidney and pancreas transplantation, in selected patients with diabetes, is the best therapy and is the only approach able to free patients from both dialysis and insulin therapy.
Keywords: diabetes; dialysis; dialysis hypotension; hemodialysis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
PATHOPHYSIOLOGY AND MANAGEMENT OF HYPOGLYCEMIAIN END-STAGE RENAL DISEASE PATIENTS: A REVIEW.Endocr Pract. 2017 Mar;23(3):353-362. doi: 10.4158/EP161471.RA. Epub 2016 Dec 14. Endocr Pract. 2017. PMID: 27967230 Review.
-
The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.JBI Libr Syst Rev. 2012;10(42 Suppl):1-10. doi: 10.11124/jbisrir-2012-170. JBI Libr Syst Rev. 2012. PMID: 27820140
-
Efficacy and safety of teneligliptin in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring.Diabetes Res Clin Pract. 2016 Dec;122:78-83. doi: 10.1016/j.diabres.2016.10.016. Epub 2016 Oct 21. Diabetes Res Clin Pract. 2016. PMID: 27810689
-
Changes of the glycemic control and therapeutic regimen for diabetes mellitus in the Japanese patients on hemodialysis.Diabetes Metab Syndr. 2015 Oct-Dec;9(4):244-6. doi: 10.1016/j.dsx.2015.02.012. Epub 2015 Mar 6. Diabetes Metab Syndr. 2015. PMID: 25866098 Clinical Trial.
-
Making sense of glucose sensors in end-stage kidney disease: A review.Front Clin Diabetes Healthc. 2022 Dec 19;3:1025328. doi: 10.3389/fcdhc.2022.1025328. eCollection 2022. Front Clin Diabetes Healthc. 2022. PMID: 36992784 Free PMC article. Review.
Cited by
-
Factors Contributing to Negative Outcomes Associated with Medications and Drug-Related Problems in Kidney Replacement Therapy-A Hospital-Based Prospective Observational Study.J Clin Med. 2024 Feb 12;13(4):1048. doi: 10.3390/jcm13041048. J Clin Med. 2024. PMID: 38398360 Free PMC article.
-
Systematic review and meta-analysis of cardiovascular event risk prediction models in maintenance hemodialysis patients.Sci Rep. 2025 Jul 1;15(1):21807. doi: 10.1038/s41598-025-07586-2. Sci Rep. 2025. PMID: 40595306 Free PMC article.
-
A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients-A Review PART II-Pharmacological Approach for Management of Elderly Patients with Peripheral Atherosclerotic Lesions outside Coronary Territory.J Clin Med. 2024 Mar 5;13(5):1508. doi: 10.3390/jcm13051508. J Clin Med. 2024. PMID: 38592348 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous